R&D lab organization The key assets of Prescott Pharmaceuticals are its capable R&D scientists who generate and evaluate countless new chemical compounds for possible product profitability. They had structured their various laboratories based on the

Question

diseases and patient classes the new drugs would treat, e.g., skin cancer, COPD, Irritable Bowel Syndrome. Recently, the scientific discoveries have made biologicals, or "large molecules," a much more promising avenue of treatment. However, the skills required to synthesize, produce, and evaluate biologicals are represented by more narrow and distinct fields of study. Scientists benefit greatly from sharing knowledge gained within their own field but they have few skills that span across these fields. How does this change affect Prescott's organization of its scientists?

Answer 1

The new developments in biologicals accentuate the functional differences among the relevant fields of study. Consider establishing an organizational structure of functional areas around the scientists where each scientist gets a molecule to study.